What Clinical Evidence Shows About Tirzepatide and Period Changes Clinical trials of tirzepatide (SURMOUNT series) documented menstrual abnormalities in a small percentage of participants, most commonly amenorrhea (absent periods) or oligomenorrhea (infrequent periods)
A KFF Health News analysis of the FDAs adverse-event reporting database found that reports involving dosing mistakes by patients or healthcare providers sharply increased from roughly 2,000 in 2020 to more than 25,000 in 2025
A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects
In laboratory settings, AOD9604 may be used to investigate pathways related to lipid turnover, cellular energy regulation, and adipose tissue signaling
The distinction between compounded and FDA-approved products - and what each designation means for safety, efficacy, and quality oversight - is worth understanding before enrolling in any program
The Benefit: Power-to-Weight Ratio For sports dependent on gravitysuch as running, cycling, or triathlonweight loss can yield immediate speed gains